WELL Health Technologies Corp.
WELL Health Technologies Corp. Fundamental Analysis
WELL Health Technologies Corp. (WHTCF) shows moderate financial fundamentals with a PE ratio of -88.83, profit margin of -0.53%, and ROE of -0.87%. The company generates $2.4B in annual revenue with strong year-over-year growth of 18.51%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 35.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze WHTCF's fundamental strength across five key dimensions:
Efficiency Score
WeakWHTCF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentWHTCF trades at attractive valuation levels.
Growth Score
ExcellentWHTCF delivers strong and consistent growth momentum.
Financial Health Score
ExcellentWHTCF maintains a strong and stable balance sheet.
Profitability Score
WeakWHTCF struggles to sustain strong margins.
Key Financial Metrics
Is WHTCF Expensive or Cheap?
P/E Ratio
WHTCF trades at -88.83 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, WHTCF's PEG of -0.12 indicates potential undervaluation.
Price to Book
The market values WELL Health Technologies Corp. at 0.76 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 3.28 times EBITDA. This is generally considered low.
How Well Does WHTCF Make Money?
Net Profit Margin
For every $100 in sales, WELL Health Technologies Corp. keeps $-0.53 as profit after all expenses.
Operating Margin
Core operations generate 7.66 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-0.87 in profit for every $100 of shareholder equity.
ROA
WELL Health Technologies Corp. generates $-0.35 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
WELL Health Technologies Corp. generates limited operating cash flow of $200.50M, signaling weaker underlying cash strength.
Free Cash Flow
WELL Health Technologies Corp. produces free cash flow of $153.32M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.60 in free cash annually.
FCF Yield
WHTCF converts 8.19% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-88.83
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.12
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.76
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.79
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.82
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.03
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.01
vs 25 benchmark
ROA
Return on assets percentage
-0.00
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How WHTCF Stacks Against Its Sector Peers
| Metric | WHTCF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -88.83 | 29.43 | Better (Cheaper) |
| ROE | -0.87% | 684.00% | Weak |
| Net Margin | -0.53% | -45067.00% (disorted) | Weak |
| Debt/Equity | 0.82 | 0.43 | Weak (High Leverage) |
| Current Ratio | 1.03 | 4.07 | Neutral |
| ROA | -0.35% | -17158.00% (disorted) | Weak |
WHTCF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews WELL Health Technologies Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
1000.91%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
264.33%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
242.05%
Industry Style: Defensive, Growth, Innovation
High Growth